XAIR - Beyond Air Inc Stock Price, Fair Value and News

1.17USD0.00 (0.00%)Market Closed

Market Summary

USD1.170.00

Market Closed

0.00%

XAIR Stock Price

View Fullscreen

XAIR RSI Chart

XAIR Valuation

Market Cap

42.2M

Price/Earnings (Trailing)

-0.63

Price/Sales (Trailing)

12.52

EV/EBITDA

-0.82

Price/Free Cashflow

-0.71

XAIR Price/Sales (Trailing)

XAIR Profitability

Operating Margin

88.44%

EBT Margin

-1237.52%

Return on Equity

-323.43%

Return on Assets

-129.68%

Free Cashflow Yield

-141.24%

XAIR Fundamentals

XAIR Revenue

Rev. Growth (Yr)

132.13%

Rev. Growth (Qtr)

63.6%

XAIR Earnings

Earnings (TTM)

-67.3M

Earnings Growth (Yr)

-27.25%

Earnings Growth (Qtr)

6.92%

Breaking Down XAIR Revenue

Last 7 days

-4.9%

Last 30 days

-32.8%

Last 90 days

-18.2%

Trailing 12 Months

-79.7%

How does XAIR drawdown profile look like?

XAIR Financial Health

Current Ratio

3.39

XAIR Investor Care

Shares Dilution (1Y)

19.77%

Diluted EPS (TTM)

-1.89

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	4.8M	0	0	0
2022	0	0	0	2.8M
2021	873.1K	0	0	0
2020	1.4M	1.3M	1.1M	1.0M
2019	7.7M	6.1M	4.6M	3.0M
2018	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Beyond Air Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 20, 2024	lisi steven a.	acquired	130,001	1.66	78,314	ceo and chairman of the board
Mar 20, 2024	carey robert	acquired	1,000,000	1.66	602,410	-
Mar 20, 2024	larson douglas quinton	acquired	19,999	1.66	12,048	chief financial officer
Dec 28, 2023	avniel amir	sold	-23,233	2.0621	-11,267	chief business officer
Dec 28, 2023	avniel amir	sold	-28,217	2.0547	-13,733	chief business officer
Dec 27, 2023	myers jeff lynn	sold	-7,578	2.214	-3,423	chief medical officer
Dec 18, 2023	lisi steven a.	bought	126,797	1.6303	77,775	ceo and chairman of the board
Dec 18, 2023	carey robert	bought	1,962,000	1.635	1,200,000	-
Nov 16, 2023	gaul michael a.	bought	17,700	1.77	10,000	chief operating officer
Aug 28, 2023	carey robert	bought	673,750	2.695	250,000	-

Which funds bought or sold XAIR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-4.84	-22,360	121,739	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	added	253	34,000	49,000	-%
Apr 25, 2024	Rosalind Advisors, Inc.	new	-	1,572,290	1,572,290	1.47%
Apr 24, 2024	Carmichael Hill & Associates, Inc.	added	14.29	200	13,920	0.01%
Apr 23, 2024	AMALGAMATED BANK	reduced	-74.96	-5,000	2,000	-%
Apr 23, 2024	GODSEY & GIBB, INC	unchanged	-	-220	1,740	-%
Apr 22, 2024	WEALTH EFFECTS LLC	reduced	-7.88	-158,580	711,660	0.26%
Apr 18, 2024	AlphaMark Advisors, LLC	unchanged	-	-	1,000	-%
Apr 16, 2024	Keel Point, LLC	reduced	-11.12	-6,273	23,462	-%
Apr 16, 2024	Powell Investment Advisors, LLC	reduced	-68.18	-61,880	24,360	0.01%

Are Funds Buying or Selling XAIR?

Are funds buying XAIR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own XAIR

No. of Funds

Unveiling Beyond Air Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 07, 2024	blackrock inc.	4.96%	1,789,582	SC 13G
Feb 14, 2024	mosseri marlio charles	9.21%	0	SC 13G/A
Jan 29, 2024	blackrock inc.	5.8%	1,857,684	SC 13G
Feb 14, 2023	mosseri marlio charles	9.99%	0	SC 13G/A
Feb 11, 2022	flynn james e	3.03%	833,334	SC 13G/A
Feb 09, 2022	mosseri marlio charles	7.76%	2,312,627	SC 13G/A
May 04, 2021	mosseri marlio charles	9.6%	0	SC 13G/A
Feb 12, 2021	allianz global investors u.s. holdings llc	0.0%	0	SC 13G/A
Mar 13, 2020	mosseri marlio charles	9.8%	0	SC 13G
Jan 23, 2020	flynn james e	5.78%	856,863	SC 13G/A

Recent SEC filings of Beyond Air Inc

View All Filings

Date Filed	Form Type	Document
Mar 22, 2024	424B5	Prospectus Filed
Mar 22, 2024	8-K	Current Report
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading
Mar 21, 2024	4	Insider Trading

Peers (Alternatives to Beyond Air Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.5B	40.1B	-5.27%	-1.83%	32.59	4.65	-8.12%	-17.45%
BDX	66.9B	19.5B	-6.10%	-12.08%	53.25	3.43	4.02%	-22.04%
ALGN	23.2B	3.9B	-5.77%	-2.75%	52.14	6.01	3.42%	23.09%
BAX	20.4B	14.8B	-6.00%	-14.25%	7.67	1.38	2.12%	209.17%
MID-CAP
ATR	9.5B	3.5B	-0.91%	22.96%	30.27	2.67	6.16%	35.06%
HSIC	9.4B	12.3B	-2.70%	-9.94%	22.59	0.76	-2.44%	-22.68%
BIO	8.1B	2.7B	-21.14%	-36.84%	-12.64	3.01	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.20%	-26.06%	-47.15	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-3.27%	17.57%	-560.12	9.28	33.86%	89.83%
PDCO	2.3B	6.6B	-7.27%	-4.94%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-12.41%	-15.32%	-1.95	0.41	7.73%	-1066.14%
ANIK	379.4M	166.7M	0.04%	-0.97%	-4.59	2.28	6.67%	-456.34%
ANGO	232.3M	324.0M	1.75%	-30.04%	-1.21	0.72	-3.19%	-337.41%
APYX	49.9M	52.3M	2.13%	-52.32%	-2.67	0.95	17.61%	19.28%
AEMD	3.6M	3.7M	-20.47%	240.00%	-0.29	0.95	5.77%	8.23%

Beyond Air Inc News

Latest updates

Beyond Air Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	63.6%	391,000	239,000	215,480	191,960	168,440	144,920	149,000	350,000	229,161	271,770	314,379	645,602	627,469	-	-
Cost Of Revenue	73.1%	748,000	432,000	303,000	-	68,000	-	-	-	-	-	-	-	-	-	-
Gross Profit	-84.5%	-356,000	-193,000	-244,000	-	-68,000	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-4.2%	16,606,000	17,342,000	15,631,000	13,681,000	13,941,000	-	5,765,000	5,316,000	-	-	5,052,336	4,914,862	-	-	2,402,561
S&GA Expenses	-4.3%	9,768,000	10,211,000	10,936,000	9,549,500	8,941,000	3,333,993	2,471,000	2,169,000	2,494,014	2,163,975	2,471,714	2,064,872	2,182,558	2,580,189	1,814,305
R&D Expenses	-4.1%	6,838,000	7,130,000	4,695,000	4,131,500	5,000,000	1,845,093	3,294,000	3,147,000	4,331,814	2,894,795	2,580,622	2,849,990	2,323,513	1,630,291	588,256
EBITDA Margin	100.0%	-	-11.93	-12.18	-12.24	-49.22	-25.21	-19.32	-17.27	-	-	-	-	-	-	-
Interest Expenses	0.5%	919,000	914,000	158,000	-112,000	46,000	169,880	158,000	159,000	163,240	26,711	750	48.00	3,034	-191,494	-
Income Taxes	-	-	-	-	-	-	-	-	-	-	-160,300	-	-	-	-	-
EBT Margin	100.0%	-	-12.38	-12.38	-12.38	-50.46	-26.20	-20.05	-17.76	-	-	-	-	-	-	-
Net Income	6.9%	-16,220,000	-17,426,000	-15,055,000	-18,618,000	-12,747,000	-5,231,500	-5,770,000	-5,132,000	-6,742,000	-5,268,332	-4,395,611	-4,097,740	-6,180,821	-71,064	-2,366,520
Net Income Margin	100.0%	-	-13.22	-12.34	-11.63	-46.16	-26.20	-22.86	-19.03	-	-	-	-	-	-	-
Free Cashflow	5.4%	-15,126,000	-15,982,000	-17,948,000	-10,431,000	-10,223,000	-5,589,000	-5,403,000	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-10.5%	52.00	58.00	73.00	69.00	74.00	82.00	92.00	99.00	99.00	54.00	44.00	41.00	25.00	24.00	27.00	27.00	17.00	11.00	13.00	9.00	4.00
Current Assets	-16.3%	39.00	47.00	63.00	59.00	66.00	75.00	85.00	93.00	95.00	50.00	41.00	37.00	23.00	23.00	26.00	27.00	16.00	10.00	12.00	9.00	3.00
Cash Equivalents	-39.5%	8.00	13.00	31.00	29.00	25.00	30.00	73.00	80.00	83.00	48.00	39.00	35.00	22.00	22.00	24.00	20.00	2.00	2.00	1.00	1.00	0.00
Inventory	-2.6%	2.00	2.00	1.00	1.00	1.00	1.00	1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-
Net PPE	25.3%	9.00	7.00	5.00	5.00	4.00	3.00	2.00	2.00	2.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Liabilities	-2.5%	28.00	29.00	34.00	27.00	19.00	18.00	21.00	21.00	9.00	13.00	11.00	10.00	8.00	8.00	9.00	9.00	5.00	6.00	5.00	5.00	1.00
Current Liabilities	-6.5%	12.00	12.00	12.00	20.00	12.00	12.00	10.00	11.00	6.00	7.00	4.00	4.00	3.00	4.00	4.00	5.00	5.00	5.00	5.00	5.00	1.00
Shareholder's Equity	-27.8%	21.00	29.00	39.00	38.00	55.00	64.00	71.00	78.00	91.00	41.00	33.00	30.00	17.00	16.00	18.00	18.00	12.00	6.00	8.00	4.00	2.00
Retained Earnings	-7.7%	-226	-209	-193	-179	-159	-146	-134	-123	-103	-95.90	-87.20	-80.46	-75.23	-69.46	-64.33	-57.59	-52.32	-47.92	-43.83	-37.64	-37.59
Additional Paid-In Capital	4.8%	247	235	229	217	210	205	200	196	189	137	121	111	92.00	86.00	83.00	76.00	64.00	53.00	52.00	42.00	40.00
Shares Outstanding	11.0%	35.00	32.00	32.00	31.00	30.00	30.00	30.00	30.00	27.00	24.00	22.00	22.00	18.00	-	-	-	-	-	-	-	-
Minority Interest	-13.9%	3.00	3.00	4.00	4.00	4.00	5.00	5.00	6.00	6.00	-	-	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	201	-	-	-	257	-	-	-	80.00	-	-	-	33.00	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	3.6%	-13,789	-14,300	-17,200	-8,431	-12,071	-2,097	-6,840	-19,208	6,300	5,000	-3,918	-5,569	-5,264	-3,320	-5,485	-4,859	-4,757	-2,723	-2,909	7,089	-1,641
Share Based Compensation	-0.4%	6,435	6,460	6,115	4,354	5,866	4,714	4,624	3,344	2,116	1,155	1,216	839	1,061	1,179	1,816	1,008	733	894	942	705	1,193
Cashflow From Investing	148.2%	853	-1,768	-9,653	8,860	4,388	-33,571	-264	-339	-419	-665	-27.00	-20.00	-139	-487	-243	12,459	-4,909	3,650	-6,775	-7,272	1,760
Cashflow From Financing	1016.8%	5,238	469	21,567	3,409	-310	133	-536	5,667	50,715	14,762	8,306	18,203	5,704	1,716	4,709	15,089	10,089	775	8,981	1,044	46.00

XAIR Income Statement

2023-12-31

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 391		$ 689
Cost of revenue	748	68	1,483	247
Gross loss	(356)	(68)	(794)	(247)
Operating expenses:
Research and development	(6,838)	(5,000)	(18,664)	(12,679)
General and administrative	(9,768)	(8,941)	(30,915)	(25,144)
Operating expenses	(16,606)	(13,941)	(49,578)	(37,823)
Operating loss	(16,963)	(14,010)	(50,372)	(38,070)
Other income (expense)
Dividend/interest income and gains on marketable securities	388	271	1,438	388
Interest expense	(919)	(46)	(1,991)	(142)
Change in fair value of warrant liability	46		693
Change in fair value of derivative liability	135		1,147
Foreign exchange gain and loss	31	286	(3)	(108)
Estimated liability for contingent loss	(11)	(248)	(609)	(248)
Other income/ (expense)	35	(52)	(42)	(71)
Total other income (expense)	(294)	211	633	(180)
Benefit from income taxes
Net loss	(17,258)	(13,798)	(49,739)	(38,250)
Less : net loss attributable to non-controlling interest	(1,038)	(1,051)	(3,204)	(2,601)
Net loss attributable to Beyond Air, Inc.	(16,220)	(12,747)	(46,535)	(35,649)
Foreign currency translation gain /(loss)	(9)	(184)	(19)	159
Comprehensive loss attributable to Beyond Air, Inc.	$ (16,229)	$ (12,931)	$ (46,554)	$ (35,490)
Net basic loss per share attributable to Beyond Air, Inc.	$ (0.50)	$ (0.43)	$ (1.46)	$ (1.19)
Net diluted loss per share attributable to Beyond Air, Inc.	$ (0.50)	$ (0.43)	$ (1.46)	$ (1.19)
Weighted average number of shares, outstanding basic	32,462,476	29,921,254	31,883,799	29,902,694
Weighted average number of shares, outstanding diluted	32,462,476	29,921,254	31,883,799	29,902,694

XAIR Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets
Cash and cash equivalents	$ 7,971	$ 29,158
Marketable securities	23,292	16,724
Restricted cash	231	7,610
Accounts receivable	294
Inventory, net	1,533	1,129
Grant receivable		420
Other current assets and prepaid expenses	6,118	4,369
Total current assets	39,439	59,410
Licensed right to use technology	1,478	1,632
Right-of-use lease assets	2,229	2,493
Property and equipment, net	8,551	5,003
Other assets	213	212
TOTAL ASSETS	51,911	68,749
Current liabilities
Accounts payable	3,220	2,016
Accrued expenses	7,882	16,613
Operating lease liability, current portion	408	376
Loans payable, current portion	130	775
Total current liabilities	11,641	19,780
Operating lease liability, net	2,012	2,321
Long-term debt	14,380	120
Warrant liability	192
Derivative liability	214
Other long-term liabilities		4,500
Total liabilities	28,440	26,721
Stockholders’ equity
Preferred Stock, $0.0001 par value per share: 10,000,000 shares authorized, 0 shares issued and outstanding
Common Stock, $0.0001 par value per share: 100,000,000 shares authorized, 35,478,123 and 30,738,585 shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively	4	3
Treasury stock	(25)	(25)
Additional paid-in capital	246,792	217,339
Accumulated deficit	(225,990)	(179,455)
Accumulated other comprehensive income	34	53
Total stockholders’ equity attributable to Beyond Air, Inc	20,814	37,915
Non-controlling interest	2,657	4,113
Total equity	23,471	42,028
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 51,911	$ 68,749

About Beyond Air Inc

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

CEO	Mr. Steven Adam Lisi
WEBSITE	beyondair.net
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	98

Beyond Air Inc Frequently Asked Questions

What is the ticker symbol for Beyond Air Inc? What does XAIR stand for in stocks?

XAIR is the stock ticker symbol of Beyond Air Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Beyond Air Inc (XAIR)?

As of Fri Apr 26 2024, market cap of Beyond Air Inc is 42.17 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XAIR stock?

You can check XAIR's fair value in chart for subscribers.

What is the fair value of XAIR stock?

You can check XAIR's fair value in chart for subscribers. The fair value of Beyond Air Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Beyond Air Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for XAIR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Beyond Air Inc a good stock to buy?

The fair value guage provides a quick view whether XAIR is over valued or under valued. Whether Beyond Air Inc is cheap or expensive depends on the assumptions which impact Beyond Air Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XAIR.

What is Beyond Air Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, XAIR's PE ratio (Price to Earnings) is -0.63 and Price to Sales (PS) ratio is 12.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XAIR PE ratio will change depending on the future growth rate expectations of investors.